Mononuclear phagocyte function and differentiation can be modulated by specific interactions of plasma membrane receptors with components of the extracellular matrix, in particular, fibronectin (Fn) (1, 2) . Some of these receptors recognize the RGDS (Arg-Gly-Asp-Ser) sequence of the cell-binding domain (3) . These receptors belong to the integrin family and have been recently isolated and partially characterized (4, 5) . Other regions of Fn, particularly within the Hep 11 domain and the type III connecting segment (IIICS), contribute to the attachment and spreading of various cells, and may be correlated with different stages of cell differentiation (reviewed in reference 6) .
Results
Characteristics of the Fn Fragments. Fig. 1 displays the position, ligand specificity, and NH2-terminal amino acid sequence of the Fn fragments used in this study. Trypsin digestion of Fn releases two different fragments containing the Hep II domain, with molecular masses of38 and 58 kD, respectively (7, 10, 11) . The difference occurs because only the A chain of Fn contains the IIICS region (12) . The 38-kD fragment comprises the first 67 amino acids of IIICS (7) and is derived from the A chain . The 38-and the 58-kD fragments have identical NH2-terminal sequences. The 58-kD fragment is derived from the B chain, does not contain the trypsin-cleavage site present in the 38-kD fragment, and lacks the entire IIICS region (10) (11) (12) . It contains the Fib II domain, has slower mobility on SDS-gels upon reduction, and reacts with N-296 mAb (data not shown).
Attachment of U937 Cells to Fn and its Fragments. U937 cells attached to plastic wells coated with Fn, and 80-and 38-kD fragments in a dose-dependent manner (Fig.  2) . The calculated concentrations required for 50% cell attachment were 14 nM (Fn), 70 nM (80 kD), and 50 nM (38 kD), indicating that the two fragments had similar attachment activity, but were four-to fivefold less effective than intact Fn. Thus, U937 cells interact with two different domains of Fn. U937 did not bind to uncoated wells or to wells coated with the 29-, 31-, or 58-kD fragments. When 2 .0 ..g/cm2 of 3H-labeled 80-, 58-, and 38-kD fragments were applied to the plates, 0.18, 0.25, and 0.31 14g/cm 2, respectively, bound to the wells. This indicates that the lack of adhesion-promoting activity of the HAD fragment was not the result of poor adsorption to the plastic.
The 38-kDFragment Contains an RGDS-independent Cell Attachment Domain. The following reagents were used in inhibition experiments to assess the specificity of U937 cell attachment to surfaces coated with 38-kD fragments: (a) anti-Fn antibodies ; (b) RGD-containing synthetic peptides ; and (c) Fn and Fn fragments.
The N-294 mAb, directed to the cell-binding domain of Fn, did not affect U937 adhesion to the 38-kD fragment, but inhibited cell attachment to Fn-coated plates (not shown) . The mAb N-296, specific for the COOH-terminal domain, had no effect . Cell adhesion to 38-kD fragment-or to Fn-coated plates was completely abolished by small doses of a polyclonal rabbit IgG anti-Fn. Thus, U937 recognized 38-kD determinants that were distinct from those of the cell-binding domain. The amount of immobilized Fn (and therefore of antibody) was probably insufficient to promote Fc-mediated cell adhesion .
Preincubation of U937 cells with the synthetic peptide GRGDSPC inhibited cell attachment to Fn-coated substrata (Fig . 3 A) , but had no effect on adhesion to 38- Model of human plasma Fn showing the location of biologically active domains. The shaded boxes represent the tryptic fragments used in this study. The NH2-terminal amino acid sequence of the fragments was: 29 kD, <EAQQMVQP-QSP; 31 kD, HRPRPYPPNV; 38 kD, TAGPDQTEMTIE ; 58 kD, TAGPDQTEMTIE; and 80 kD, SD()VPSPR()L . An asterisk marks the position of the RGDS . The darkened area IIICS is present only on the A chain, and on the 38-and 31-kD fragments. The 38-kD fragment contains the first 67 amino acid residues of IIICS; the three overlapping synthetic peptides, CS-1, CS-2, and CS-3, were based on this sequence. kD-coated wells (Fig. 3 B) . The control peptide GRGESP had no effect in either case. Preincubation of U937 cells with the soluble 38-kD fragment abolished cell attachment to 38-kD-coated wells ( Fig. 3 C) ; preincubation with Fn or with the 80-kD fragment had no effect . These results indicated that U937 interaction with the 38-kD domain did not involve the RGDS sequence or the cell surface receptors that recognize this region .
The relative contribution of the fragments to U937 adhesion to Fn was evaluated using 38-and 80-kD fragments and intact Fn as soluble inhibitors . Preincubation of U937 with 1.2 mg/ml of the 80-kD fragment reduced cell attachment to Fn by 90% (Fig. 3 D) . The 38-kD fragment produced 55% inhibition at the same dose . The 80-kD fragment was 30-fold more effective in producing half-maximal inhibition than the 38-kD fragment (0.38 vs. 12 pM). Preincubation of the cells with soluble Fn had no effect on their subsequent adhesion to Fn-coated wells, in agreement with previously reported results (4).
Identification ofthe Region ofthe 38-kD Domain that Promotes CellAdhesion . U937 cells bound to wells coated with the 38-kD fragment, but did not bind to wells coated with the 58-kD fragment, suggesting that cell attachment might be mediated by the unique IIICS region of the A chain, absent from the 58-kD fragment . To confirm this observation and locate the binding region, synthetic peptides representing three regions of IIICS were used as inhibitory probes in cell attachment assays . The CS-1 peptide (residues 1-25) inhibited attachment of U937 to 38-kD-coated substrata in a dose-dependent manner (Fig. 4 A) . This effect could be reversed by increasing the concentration of substratum-bound 38-kD fragments (not shown). The other two peptides, CS-2 (residues 22-46) and CS-3 (residues 43-67), had no effect . None of the peptides inhibited attachment of U937 cells to Fn-coated wells (Fig. 4 B) . U937 interaction with the 38-kD fragment did not involve recognition of RGDS, because the 80-kD fragment and the RGDS-containing peptide did not inhibit cell attachment to 38-kD fragment-coated wells. Consequently, the 38-kD fragment contains a second interacting site for U937 cells. The experiments described also suggest that the heparin-binding site of the 38-kD fragment is not involved in U937 adhesion, because two other fragments, the 29-kD fragment containing the Hep I domain, and the 58-kD fragment containing the Hep II domain, failed to support cell attachment .
The synthetic peptides CS-1, CS-2, and CS-3 allowed mapping of the U937 attachment site to the first 25 amino acid residues of the IIICS region . This region was previously shown to mediate attachment and spreading of murine melanoma and avian neural crest cells (6) .
The presence of different cell-binding sites on Fn may have distinct functional significance. For example, cell interactions with a second Fn site may regulate the delivery of intracellular signals. In addition, the sequence of the CS-1 peptide can be present or absent from Fn subunits, due to alternative splicing mechanisms (12) . Fibroblasts, the major producers of cellular Fn, can synthesize Fn molecules with and without CS-1 . Therefore, fibroblasts could play a role in the regulation of monocyte interactions with extracellular matrices by varying the type of Fn deposited. Plasma Fn contains both cell-binding sites, the RGDS and the CS-1 . Thus, extravasation of plasma Fn during inflammatory processes generates a uniform matrix with high attachment capacity for monocyte accumulation and differentiation. Future studies of the tissue distribution of Fn forms, and of the functional consequences of the interaction of monocytes with CS-1, may help in the elucidation of molecular mechanisms that modulate the behavior of mononuclear phagocytes . Summary U937 cells attach to the RGDS-containing 80-kD fragment of fibronectin (Fn) . The present report examined whether these cells recognize other domains of Fn . U937 cells attach to a 38-kD fragment derived from the A chain of Fn, which includes the Hep 11 domain and most of the alternatively spliced IIICS region . U937
